|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1996-7-9
|
|
pubmed:abstractText |
We compared hematologic and clinical effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) after treatment with high-dose cyclophosphamide (HD-CTX, 7 g/m2), given as the first phase of a high-dose sequential chemotherapy program that includes a myeloablative therapy with mobilized progenitor cell autografting.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
628-35
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8636780-Adult,
pubmed-meshheading:8636780-Antineoplastic Agents, Alkylating,
pubmed-meshheading:8636780-Breast Neoplasms,
pubmed-meshheading:8636780-Cyclophosphamide,
pubmed-meshheading:8636780-Female,
pubmed-meshheading:8636780-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:8636780-Granulocyte-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:8636780-Hodgkin Disease,
pubmed-meshheading:8636780-Humans,
pubmed-meshheading:8636780-Lymphoma, Non-Hodgkin,
pubmed-meshheading:8636780-Male,
pubmed-meshheading:8636780-Middle Aged
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy.
|
|
pubmed:affiliation |
Cristina Gandini Transplantation Unit, Department of Cancer Medicine, Istituto Nazionale, Tumori, Milano, Italy.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
